Home
Resources
Publications
Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies

Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies

Ashkan Heshmatzadeh Behzadi, Syed Imran Raza, John A Carrino, Christos Kosmas, Ali Gholamrezanezhad, Kyle Basques, George R Matcuk Jr, Jay Patel, Hossein Jadvar

PET Clin. 2018 Oct;13(4):623-634.

PMID: 30219192

Abstract:

Primary bone malignancies are characterized with anatomic imaging. However, in recent years, there has been an increased interest in PET/computed tomography scanning and PET/MRI with fludeoxyglucose F 18 for evaluating and staging musculoskeletal neoplasms. These hybrid imaging modalities have shown promise largely owing to their high sensitivity, ability to perform more thorough staging, and ability to monitor treatment response. This article reviews the current role of PET/computed tomography scanning and PET/MRI in primary malignancies of bone, with an emphasis on imaging characteristics, clinical usefulness, and current limitations.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP29702430	Fludeoxyglucose		29702-43-0	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: